183 related articles for article (PubMed ID: 35022213)
1. Genetic, Pharmacogenomic, and Immune Landscapes of Enhancer RNAs Across Human Cancers.
Zhang Z; Luo M; Li Q; Liu Y; Lussier C; Zhang J; Ye Y; Guo AY; Han L
Cancer Res; 2022 Mar; 82(5):785-790. PubMed ID: 35022213
[TBL] [Abstract][Full Text] [Related]
2. Genome-wide enhancer RNA profiling adds molecular links between genetic variation and human cancers.
Cai YM; Lu ZQ; Li B; Huang JY; Zhang M; Chen C; Fan LY; Ma QY; He CY; Chen SN; Jiang Y; Li YM; Ning CB; Zhang FW; Wang WZ; Liu YZ; Zhang H; Jin M; Wang XY; Han JX; Xiong Z; Cai M; Huang CQ; Yang XJ; Zhu X; Zhu Y; Miao XP; Zhang SK; Wei YC; Tian JB
Mil Med Res; 2024 Jun; 11(1):36. PubMed ID: 38863031
[TBL] [Abstract][Full Text] [Related]
3. HeRA: an atlas of enhancer RNAs across human tissues.
Zhang Z; Hong W; Ruan H; Jing Y; Li S; Liu Y; Wang J; Li W; Diao L; Han L
Nucleic Acids Res; 2021 Jan; 49(D1):D932-D938. PubMed ID: 33119754
[TBL] [Abstract][Full Text] [Related]
4. Transcriptional landscape and clinical utility of enhancer RNAs for eRNA-targeted therapy in cancer.
Zhang Z; Lee JH; Ruan H; Ye Y; Krakowiak J; Hu Q; Xiang Y; Gong J; Zhou B; Wang L; Lin C; Diao L; Mills GB; Li W; Han L
Nat Commun; 2019 Oct; 10(1):4562. PubMed ID: 31594934
[TBL] [Abstract][Full Text] [Related]
5. The Genetic, Pharmacogenomic, and Immune Landscapes Associated with Protein Expression across Human Cancers.
Chen C; Liu Y; Li Q; Zhang Z; Luo M; Liu Y; Han L
Cancer Res; 2023 Nov; 83(22):3673-3680. PubMed ID: 37548539
[TBL] [Abstract][Full Text] [Related]
6. eaQTLdb: An atlas of enhancer activity quantitative trait loci across cancer types.
Yuan J; Tong Y; Liu X; Li MJ; Zhang Q; Yang Y
Int J Cancer; 2023 Jul; 153(1):111-119. PubMed ID: 36840614
[TBL] [Abstract][Full Text] [Related]
7. Inflammatory Immune-Associated eRNA: Mechanisms, Functions and Therapeutic Prospects.
Wan L; Li W; Meng Y; Hou Y; Chen M; Xu B
Front Immunol; 2022; 13():849451. PubMed ID: 35514959
[TBL] [Abstract][Full Text] [Related]
8. Pig-eRNAdb: a comprehensive enhancer and eRNA dataset of pigs.
Wang Y; Jin W; Pan X; Liao W; Shen Q; Cai J; Gong W; Tian Y; Xu D; Li Y; Li J; Gong J; Zhang Z; Yuan X
Sci Data; 2024 Feb; 11(1):157. PubMed ID: 38302497
[TBL] [Abstract][Full Text] [Related]
9. A High-Resolution Map of Human Enhancer RNA Loci Characterizes Super-enhancer Activities in Cancer.
Chen H; Liang H
Cancer Cell; 2020 Nov; 38(5):701-715.e5. PubMed ID: 33007258
[TBL] [Abstract][Full Text] [Related]
10. HPSE enhancer RNA promotes cancer progression through driving chromatin looping and regulating hnRNPU/p300/EGR1/HPSE axis.
Jiao W; Chen Y; Song H; Li D; Mei H; Yang F; Fang E; Wang X; Huang K; Zheng L; Tong Q
Oncogene; 2018 May; 37(20):2728-2745. PubMed ID: 29511351
[TBL] [Abstract][Full Text] [Related]
11. Enhancer RNA (eRNA) in Human Diseases.
Wang Y; Zhang C; Wang Y; Liu X; Zhang Z
Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232885
[TBL] [Abstract][Full Text] [Related]
12. Enhancer RNAs step forward: new insights into enhancer function.
Harrison LJ; Bose D
Development; 2022 Aug; 149(16):. PubMed ID: 36039999
[TBL] [Abstract][Full Text] [Related]
13. Comprehensive characterization of functional eRNAs in lung adenocarcinoma reveals novel regulators and a prognosis-related molecular subtype.
Qin N; Ma Z; Wang C; Zhang E; Li Y; Huang M; Chen C; Zhang C; Fan J; Gu Y; Xu X; Yang L; Wei X; Yin R; Jiang Y; Dai J; Jin G; Xu L; Hu Z; Shen H; Ma H
Theranostics; 2020; 10(24):11264-11277. PubMed ID: 33042282
[No Abstract] [Full Text] [Related]
14. The dynamic landscape of enhancer-derived RNA during mouse early embryo development.
Yu H; Zhao J; Shen Y; Qiao L; Liu Y; Xie G; Chang S; Ge T; Li N; Chen M; Li H; Zhang J; Wang X
Cell Rep; 2024 Apr; 43(4):114077. PubMed ID: 38592974
[TBL] [Abstract][Full Text] [Related]
15. Functional roles of antisense enhancer RNA for promoting prostate cancer progression.
Pan CW; Wen S; Chen L; Wei Y; Niu Y; Zhao Y
Theranostics; 2021; 11(4):1780-1794. PubMed ID: 33408781
[No Abstract] [Full Text] [Related]
16. Population-scale study of eRNA transcription reveals bipartite functional enhancer architecture.
Kristjánsdóttir K; Dziubek A; Kang HM; Kwak H
Nat Commun; 2020 Nov; 11(1):5963. PubMed ID: 33235186
[TBL] [Abstract][Full Text] [Related]
17. Enhancer RNA: What we know and what we can achieve.
Han Z; Li W
Cell Prolif; 2022 Apr; 55(4):e13202. PubMed ID: 35170113
[TBL] [Abstract][Full Text] [Related]
18. DCP1A is an unfavorable prognostic-related enhancer RNA in hepatocellular carcinoma.
Wu H; Zhang J; Bai Y; Zhang S; Zhang Z; Tong W; Han P; Fu B; Zhang Y; Shen Z
Aging (Albany NY); 2021 Oct; 13(19):23020-23035. PubMed ID: 34609335
[TBL] [Abstract][Full Text] [Related]
19. Enforced Activation of Enhancer RNAs In Situ through the dCas9 Synergistic Activation Mediator System.
Liao Z; Lee JH; Krakowiak J; Wang R; Li W
J Vis Exp; 2020 Jun; (160):. PubMed ID: 32568241
[TBL] [Abstract][Full Text] [Related]
20. Differential activity of transcribed enhancers in the prefrontal cortex of 537 cases with schizophrenia and controls.
Hauberg ME; Fullard JF; Zhu L; Cohain AT; Giambartolomei C; Misir R; Reach S; Johnson JS; Wang M; Mattheisen M; Børglum AD; Zhang B; Sieberts SK; Peters MA; Domenici E; Schadt EE; Devlin B; Sklar P; Roeder K; Roussos P;
Mol Psychiatry; 2019 Nov; 24(11):1685-1695. PubMed ID: 29740122
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
